 Home / Cancer / Hydrea, droxia |
 |
||||||||||||||||||||||||
Buy Hydrea, Droxia Buy Hydrea (hydroxyurea) to treat melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary. Hydrea is also used concomitantly with irradiation therapy is intended for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip.. Initial dosage will depend on condition. The initial dosage is usually 80 mg/kg administered orally as a single dose every third day.Contraindications: Hydrea is contraindicated in people who have hypersensitivity to ingredients in Hydrea and patients with marked bone marrow depression, leukopenia ( low white blood cell count) or thrombocytopenia (relatively few platelets in blood), or severe anemia. To read more about Hydrea, Droxia side effects, Hydrea, Droxia dosage, and for more useful information about Hydrea, Droxia , please click the product information link below.  PRODUCT INFORMATION
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
Other name(s): Hydroxyurea |
||||||||||||||||||||||||
Often prescribed for Melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary |
||||||||||||||||||||||||
READ MORE ABOUT CANCER
Hydrea, DroxiaChemical NameHydroxyurea Ingredients Active Ingredients: Hydroxyurea Non-Active Ingredients: Citric acid, colorants (D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red 40, and D&C Red 28), gelatin, lactose, magnesium stearate, sodium phosphate, and titanium dioxide. Indications Hydrea is indicated in the treatment of melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary. Often used in conjunction with irradiation therapy, it is used for the local control of squamous cell (epidermoid) carcinomas that are found on the head and neck, not including the lip. How It Works Hydroxycarbamide increases nitric oxide levels, causing soluble guanylyl cyclase activation with a resultant rise in cyclic GMP, and the activation of gammaglobulin synthesis necessary for fetal hemoglobin (by removing the rapidly dividing cells that preferentially produce sickle hemoglobin). Dosage Tablets (500mg) Intermittent Therapy 80 mg/kg administered orally as a single dose every third day Continuous Therapy 20 to 30 mg/kg administered orally as a single dose daily Concomitant Therapy with Irradiation Carcinoma of the head and neck—80 mg/kg administered orally as a single dose every third day. Resistant Chronic Myelocytic Leukemia Until the intermittent therapy regimen has been evaluated, continuous therapy (20 to 30 mg/kg administered orally as a single dose daily) is recommended. BUY HYDREA ONLINEPrecautions Hydrea is contraindicated in people who have hypersensitivity to ingredients in Hydrea and patients with marked bone marrow depression, i.e., leukopenia ( low white blood cell count) or thrombocytopenia (relatively few platelets in blood), or severe anemia. Therapy with this drug requires supervision. While on Hydrea, a doctor should test hemoglobin level, total leukocyte counts, and platelet counts. These should be performed at least once a week. Use with caution in patients with kidney dysfunction. Close monitoring for signs of pancreatic (inflammation of the pancreas) is warranted. While taking this drug there is a chance of liver toxicity. When taking this medication, seek monitoring from a doctor. The effectiveness of this medication in children has not been established. There is chance of fertility impairment in males while on this medication. Do not treat with Hydrea if bone marrow function is depressed as bone marrow suppression may occur. Patients who have had radiation therapy may provoke or exacerbate post-irradiation skin redness. Fatal pancreatits (inflammation of the pancreas) has occurred in patients who have HIV and undergoing therapy with Hydrea. Liver toxicity and fatal liver disorder has occurred in patients with HIV using hydroxyurea, didanosine, and stavudine. This combination should be avoided. Extreme caution is warranted. Peripheral nervous system damage has occured in patients who are HIV infected. Patients with sever anemia, must be corrected before taking Hydrea. Erythrocytic abnormalities can happen during therapy. It resembles pernicious anemia, but is not related to vitamin B12 or folic acid deficiency, blood disorders that resemble vitamin B12 deficiency. Elderly patients will be more affected by Hydea. Secondary leukemia has been reported. It is unknown whether this leukemogenic effect is secondary to hydroxyurea or is associated with the patient's underlying disease. Skin cancer has also been reported in patients receiving long-term hydroxyurea. This medicine may cause harm to an unborn baby. Before taking Hydrea, tell your doctor if you are pregnant or plan to become pregnant during treatment. Hydrea may pass into breast milk and may cause harm to a nursing baby. Consult your doctor before using this medication if you are pregnant or breast-feeding a baby. You should consult a doctor before using this medication if you are allergic to hydroxyurea or similar medicines, or any of the other ingredients of Hydrea . Drug Interactions Consult a doctor before taking Hydrea, if you are taking other myelosuppressive agents, didanosine, stavudine, interferon. Before using this Hydrea, tell your doctor or pharmacist about all prescription and nonprescription medications, including herbal products, minerals and vitamins you may be taking. Other medications may affect how Hydrea works or may cause other unforeseen complications. Adverse/Side Effects It is common that Hydrea causes the following minor side effects: nausea, vomiting, loss of appetite, mouth sores, diarrhea, or constipation may occur. If these side effects persist or become overly bothersome contact your doctor or health-care professional. Infrequent side effects: Few platelets in blood, lower amount of red blood cells, anemia, gastrointestinal problems, anorexia, vomiting, diarrhea, constipation, rash, skin ulcerations, facial and skin redness, dark spots on the skin, atrophy of skin and nails, abnormal shedding of skin, flat violet colored lesions, headache, dizziness, disorientation, hallucinations convulsions, inflammation of mucous membrane, pain difficult urination, baldness, disorientation, headache, dizziness, hallucinations, convulsions, blood urea nitrogen, fever chill, malaise and fluid under the skin causing dropsy. If any of these side effects become bothersome, seek medical attention immediately. A very serious allergic reaction to this drug is rare. Get emergency medical help if you have any of these signs of an allergic reaction: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing. This may not be a complete list of side effects and may be subject to change, consult with your doctor or pharmacist if you are experiencing any worrisome side effects. Overdose Some symptoms of overdose include soreness, ultra-violet erythema, edema on palms and soles followed by scaling of hands and feet, severe generalized hyperpigmentation of the skin, and stomatitis. If you suspect overdose, contact your local poison control center or emergency room immediately. Storage Instructions Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F), away from moisture and light, and out of reach of children and pets. BUY HYDREA ONLINE
|
